share_log

BioCryst Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Chief Commercial Officer Gayer Charles K

SEC announcement ·  Dec 20, 2023 16:38
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more